Leukemia Inhibitory Factor and Stat3 Activation in Mouse Mammary Tumors
Author Information
Author(s): Quaglino Ana, Schere-Levy Carolina, Romorini Leonardo, Meiss Roberto P, Kordon Edith C
Primary Institution: IFIBYNE (CONICET), Facultad de Ciencias Exactas y Naturales, University of Buenos Aires, Argentina
Hypothesis
Locally produced LIF can be responsible for Stat3 activation in mouse mammary tumors.
Conclusion
LIF is overexpressed in mouse mammary tumors, where it acts as the main Stat3 activator, but its positive effect on tumor cell viability is not dependent on Stat3 activation.
Supporting Evidence
- LIF expression was found in all analyzed mammary tumors, indicating its role in tumor biology.
- Stat3 activation was significantly higher in hormone-dependent tumors compared to poorly differentiated tumors.
- Blocking LIF with antibodies inhibited Stat3 activation in mammary tumor cells.
- LIF increased tumor cell viability, suggesting a dual role in promoting growth and survival.
- Stat3 activation was shown to inhibit cell survival in normal mammary epithelial cells.
Takeaway
LIF is a protein that helps tumors grow by turning on a switch called Stat3, but in some cases, it can actually help the tumor cells survive without using that switch.
Methodology
The study involved analyzing LIF and Stat3 expression in various mouse mammary tumor cell lines and using blocking antibodies and pharmacological inhibitors to assess their roles in Stat3 activation.
Limitations
The study primarily focuses on mouse models, which may not fully replicate human breast cancer biology.
Participant Demographics
Female BALB/c mice, 8 to 12 weeks old.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website